Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2014 | MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer. | Thirumurthi, U; Shen, J; Xia, W; LaBaff, AM; Wei, Y; Li, CW; Chang, WC; Chen, CH; Lin, HK; Yu, D; Hung, MC | Science signaling 7(336), ra71 | | | |
2018 | Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1. | Cha, JH; Yang, WH; Xia, W; Wei, Y; Chan, LC; Lim, SO; Li, CW; Kim, T; Chang, SS; Lee, HH; Hsu, JL; Wang, HL; Kuo, CW; Chang, WC; Hadad, S; Purdie, CA; McCoy, AM; Cai, S; Tu, Y; Litton, JK; Mittendorf, EA; Moulder, SL; Symmans, WF; Thompson, AM; Piwnica-Worms, H; Chen, CH; Khoo, KH ; Hung, MC | Molecular cell 71(4), 606-620.e7 | | | |
2016 | Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation. | Wang, Y; Hsu, JM; Kang, Y; Wei, Y; Lee, PC; Chang, SJ; Hsu, YH; Hsu, JL; Wang, HL; Chang, WC; Li, CW ; Liao, HW; Chang, SS; Xia, W; Ko, HW; Chou, CK; Fleming, JB; Wang, H; Hwang, RF; Chen, Y; Qin, J; Hung, MC | Cancer research 76(23), 7049-7058 | | | |
2019 | Palmitoylation stabilizes PD-L1 to promote breast tumor growth. | Yang, Y; Hsu, JM; Sun, L; Chan, LC; Li, CW ; Hsu, JL; Wei, Y; Xia, W; Hou, J; Qiu, Y; Hung, MC | Cell research 29(1), 83-86 | | | |
2017 | PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. | Jiao, S; Xia, W; Yamaguchi, H; Wei, Y; Chen, MK; Hsu, JM; Hsu, JL; Yu, WH; Du, Y; Lee, HH; Li, CW ; Chou, CK; Lim, SO; Chang, SS; Litton, J; Arun, B; Hortobagyi, GN; Hung, MC | Clinical cancer research : an official journal of the American Association for Cancer Research 23(14), 3711-3720 | | | |